Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: PERFUSION MEDICAL LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-09-15 to 2026-01-14
Current total value of award: $2986772.93
Description: DHA SBIR DIRECT TO PHASE II MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2D-0122 FOR "IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC"